Angelini Pharma is the pharmaceutical division of the Angelini Group.
It is and international group in healthcare, present in Pharmaceuticals and Mass-Market.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the fields of Central Nervous System (CNS) and Mental Health, including Pain, and Rare Diseases. The company is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
Angelini products are marketed in about 70 countries. The company operates directly in 25 countries employing more than 3.000 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
As part of its internationalisation strategy, Angelini Pharma has also concentrated on development in countries with high growth potential.
Angelini Pharma is an integrated pharmaceutical company, with an extensive R&D operation that has developed important molecules such as trazodone and benzydamine.
Current research focuses on Nervous System Diseases and Disorders, Pain and Inflammation and Rare Diseases, with a particular commitment to the research of new treatments for the paediatric population.
The research embraces public-private partnerships with recognised academic institutions and centres of global importance. The Scientific Network and Partnerships both have an important role in creating innovation.
Angelini Pharma in figures
- 3,000 Employees
- 5 Production plants worldwide
- 50% Turnover from abroad
- 70 Countries in which products are marketed
Angelini's “world class” production plants use cutting-edge technologies and have full certification for quality standards and respect for the environment.
In Italy, finished pharmaceutical products are produced in the Ancona plant, while the industrial factory in Aprilia produces pharmaceutical raw materials. Disinfectants and sanitising products under the Amuchina brand are produced in Casella. These sites make extensive use of renewable energy sources and meet criteria of sustainability. Finally, the Albany (Georgia, USA) plant produces self-heating wraps under the ThermaCare® brand and the Barcelona plant (Spagna) produces food supplements such as Pastillas Juanola.
Angelini Pharma has offices in Italy, Spain, Portugal, Austria, Poland, Czech Republic, Slovakia, Hungary, Germany, Romania, Bulgaria, Greece, Turkey, France, UK, Sweden, The Netherlands, Switzerland, Belgium, Denmark, Finland, Norway, Iceland, Russia, and USA.
In line with its international strategies, Angelini Pharma has promoted pathways for development in countries with high growth potential, with both targeted acquisitions and enhancement of existing structures.
Moreover, important strategic alliances with leading pharmaceutical groups with a global footprint allow the distribution of Angelini Pharma products worldwide.
In the last 10 years, the percentage sales outside Italy has grown constantly, reaching about 50% of total pharma sales today.
Visit our website